RGEN Q1 2022 Earnings — Repligen Corporation Revenue & Financial Results | Market Cap Arena

RGENRepligen Corporation

$7B

Q1 2022 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$206M+44.5% YoY

Gross Profit

$124M60.1% margin

Operating Income

$60M29.1% margin

Net Income

$47M22.8% margin

EPS (Diluted)

$0.80

QoQ Revenue Growth

+10.7%

Cash Flow

Operating Cash Flow

$23M

Free Cash Flow

-$5M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$2.4B

Total Liabilities

$617M

Stockholders' Equity

$1.8B

Cash & Equivalents

$585M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$206M	$143M	+44.5%
Gross Profit	$124M	$83M	+49.3%
Operating Income	$60M	$36M	+64.9%
Net Income	$47M	$29M	+59.5%

Revenue Segments

Product

$206M100%

Royalty

$37,0000%